Interview with Drs. Mary Beth Harler and Robert Plenge from Bristol Myers Squibb
Listen now
Description
Dr. Freire hosts an engaging and informative conversation with two scientists from Bristol Myers Squibb: Dr. Mary Beth Harler, Senior Vice President, Head of Immunology & Fibrosis Development, Global Drug Development and Dr. Robert Plenge, Senior Vice President, Research & Early Development and Head of the Immunology, Cardiovascular, Fibrosis, and Global Health Thematic Research Center team. Learn how treatments for COVID-19 are addressed along the continuum from initial work in the lab to patient care. Drs. Freire, Harler and Plenge also discuss the importance of looking at the biology of this virus to identify the best treatment options.
More Episodes
Listen in as Dr. Maria Freire explores the work of Dr. Paul Stoffels, Johnson & Johnson’s Vice Chairman of the Executive Committee and Chief Scientific Officer, and his team as they have worked since April 2020 developing COVID-19 vaccines and monitoring emerging variants. Along with Dr....
Published 08/09/21
In this episode, Dr. Maria Freire sits down with Dr. Anne Schuchat, Principal Deputy Director of the Centers for Disease Control and Prevention. Learn how the CDC evaluates data when issuing guidance to the public, as well as its role in surveillance of new COVID-19 variants. According to Dr....
Published 06/03/21